Yifeng Pharmacy (603939) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Yifeng Pharmacy (603939) has a cash flow conversion efficiency ratio of 0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥641.93 Million ≈ $93.93 Million USD) by net assets (CN¥11.66 Billion ≈ $1.71 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 603939 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Yifeng Pharmacy - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Yifeng Pharmacy's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Yifeng Pharmacy Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yifeng Pharmacy ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SolarEdge Technologies Inc
NASDAQ:SEDG
|
0.059x |
|
Hanmi Pharm Co Ltd
KO:128940
|
0.031x |
|
Wockhardt Limited
NSE:WOCKPHARMA
|
-0.005x |
|
Hengan International Group Company Limited
F:HGNC
|
0.067x |
|
Shenyang Jinshan Energy Co Ltd
SHG:600396
|
0.098x |
|
GEK TERNA Holdings Real Estate Construction S.A
AT:GEKTERNA
|
0.030x |
|
HARBOUR ENE.SP.ADR LS-50
F:PQQ2
|
N/A |
|
Shenzhen Hopewind Elec Co Ltd
SHG:603063
|
0.038x |
Annual Cash Flow Conversion Efficiency for Yifeng Pharmacy (2011–2024)
The table below shows the annual cash flow conversion efficiency of Yifeng Pharmacy from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Yifeng Pharmacy (603939) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥11.39 Billion ≈ $1.67 Billion |
CN¥4.22 Billion ≈ $617.70 Million |
0.370x | -17.00% |
| 2023-12-31 | CN¥10.45 Billion ≈ $1.53 Billion |
CN¥4.66 Billion ≈ $682.38 Million |
0.446x | +3.86% |
| 2022-12-31 | CN¥9.12 Billion ≈ $1.33 Billion |
CN¥3.92 Billion ≈ $573.66 Million |
0.430x | +57.21% |
| 2021-12-31 | CN¥7.86 Billion ≈ $1.15 Billion |
CN¥2.15 Billion ≈ $314.61 Million |
0.273x | +18.34% |
| 2020-12-31 | CN¥5.78 Billion ≈ $846.10 Million |
CN¥1.34 Billion ≈ $195.45 Million |
0.231x | +12.93% |
| 2019-12-31 | CN¥4.71 Billion ≈ $689.07 Million |
CN¥963.23 Million ≈ $140.95 Million |
0.205x | +67.01% |
| 2018-12-31 | CN¥4.17 Billion ≈ $610.18 Million |
CN¥510.71 Million ≈ $74.73 Million |
0.122x | +22.77% |
| 2017-12-31 | CN¥3.18 Billion ≈ $465.28 Million |
CN¥317.20 Million ≈ $46.42 Million |
0.100x | +112.11% |
| 2016-12-31 | CN¥2.98 Billion ≈ $435.39 Million |
CN¥139.94 Million ≈ $20.48 Million |
0.047x | -63.22% |
| 2015-12-31 | CN¥1.42 Billion ≈ $207.70 Million |
CN¥181.52 Million ≈ $26.56 Million |
0.128x | -64.12% |
| 2014-12-31 | CN¥595.76 Million ≈ $87.18 Million |
CN¥212.35 Million ≈ $31.07 Million |
0.356x | +14.22% |
| 2013-12-31 | CN¥502.20 Million ≈ $73.49 Million |
CN¥156.71 Million ≈ $22.93 Million |
0.312x | +64.60% |
| 2012-12-31 | CN¥425.82 Million ≈ $62.31 Million |
CN¥80.73 Million ≈ $11.81 Million |
0.190x | -45.08% |
| 2011-12-31 | CN¥356.28 Million ≈ $52.14 Million |
CN¥122.99 Million ≈ $18.00 Million |
0.345x | -- |
About Yifeng Pharmacy
Yifeng Pharmacy Chain Co., Ltd. engages in the retail business of pharmaceutical products in China. The company operates through Retail business and Wholesale business segments. It offers Western and Chinese patent medicine, traditional Chinese medicine herbal pieces, medical devices and equipment, health supplements and products, personal care products, drugs, and convenience products related to… Read more